Your session is about to expire
← Back to Search
Poly-phenylpropanoid-polysaccharide complex
capsule for Allergic Rhinitis (PCE Trial)
N/A
Waitlist Available
Led By Dennis Ledford, M.D.
Research Sponsored by University of South Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Summary
This trial tests a pine cone extract on adults with year-round nasal allergies. The extract aims to reduce substances in the body that cause allergy symptoms. Participants will take the extract daily for a period of time to see if it helps with their allergies.
Eligible Conditions
- Allergic Rhinitis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Primary Objective ( total serum IgE)
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: capsuleActive Control1 Intervention
patinets receiveing pine cone extract tablets
Group II: placebo capsulePlacebo Group1 Intervention
patinets receiving placebo
Find a Location
Who is running the clinical trial?
University of South FloridaLead Sponsor
425 Previous Clinical Trials
190,439 Total Patients Enrolled
Dennis Ledford, M.D.Principal InvestigatorDivision of Allergy and Immunology, USF
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have year-round allergy symptoms with or without seasonal allergies.You need to be at least 18 years old to participate.
Research Study Groups:
This trial has the following groups:- Group 1: placebo capsule
- Group 2: capsule
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger